(Q37783454)

23 August 2017

title

A critical re-appraisal of BRCA1 methylation studies in ovarian cancer (English)

1 reference

23 August 2017

1 reference

Emir Senturk

1

1 reference

23 August 2017

Samantha Cohen

series ordinal

2

1 reference

23 August 2017

Peter R Dottino

series ordinal

3

1 reference

23 August 2017

John A Martignetti

series ordinal

4

1 reference

23 August 2017

language of work or name

English

0 references

publication date

24 August 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

119

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

376-383

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

23 August 2017

1 reference

The contribution of BRCA1 and BRCA2 to ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Mutations of the BRCA1 gene in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Mutation and cancer: statistical study of retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Improved survival in women with BRCA-associated ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

BRCA1 promoter methylation predicts adverse ovarian cancer prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

CpG islands--'a rough guide'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Initial sequencing and analysis of the human genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Aberrant DNA methylation as a cancer-inducing mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

DNA methylation markers in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Identification of novel DNA methylation markers in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

DNA hypermethylation: when tumour suppressor genes go silent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Genomic DNA methylation: the mark and its mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Myc represses transcription through recruitment of DNA methyltransferase corepressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

DNA methylation: the nuts and bolts of repression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Distinct transcription start sites generate two forms of BRCA1 mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Positive regulation of the BRCA1 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Regulation of the BRCA1 promoter in ovarian surface epithelial cells and ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

GA-binding protein alpha/beta is a critical regulator of the BRCA1 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Targeting the epigenome for the treatment and prevention of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.07.026

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2010.07.026

1 reference

23 August 2017

1 reference